Log in or Sign up for Free to view tailored content for your specialty!
Ocular Oncology News
Trial to look at vismodegib as treatment for orbital basal cell carcinoma
A proposed clinical trial of vismodegib, a novel once-daily oral therapy, to treat orbital and periorbital basal cell carcinoma should begin recruiting in the spring, according to a physician.
Chemoreduction with cyclophosphamide controls retinoblastoma progression
Chemoreduction with cyclophosphamide controlled progression of retinoblastoma while preventing the need for enucleation and external beam radiotherapy, a study found.
Log in or Sign up for Free to view tailored content for your specialty!
Uveal melanoma samples to be stored for future research
Patients who provide tissue for a uveal melanoma gene test will have the option of having a sample of the tumor stored for up to 5 years so that it can be used in potential future developments related to the disease, according to a news release from Castle Biosciences.
Euretina Medal Lecturer lauds proton beam irradiation
HAMBURG — Proton beam irradiation has been a major breakthrough in the treatment of uveal melanoma, overcoming several limitations of previous systems and providing tumor control over 10 years in 98% of cases, a speaker said here.
Neoadjuvant intra-arterial cytoreductive chemotherapy may improve survival in patients with lacrimal gland adenoid cystic carcinoma
Patients with lacrimal gland adenoid cystic carcinoma may be treated with neoadjuvant intra-arterial cytoreductive chemotherapy instead of conventional treatment for improved survival, according to a study.
In vivo OCT images linked to postoperative histology of periocular basal cell carcinoma
In vivo OCT imaging had a positive association with postoperative histology of periocular basal cell carcinoma of the eyelids, according to a study.
Older woman presents with chronic right upper lid cystic lesion
A 71-year-old woman presented to the New England Eye Center Oculoplastics Department for a right upper lid lesion that was present for approximately 1 year. She said that it did not change in appearance or size and was tender to touch. The lesion did not reduce in size despite weeks of warm compresses. Her medical history included diabetes type 2, gout, cardiac murmur, hypertension, hyperlipidemia and hypothyroidism, all of which were being treated with medications.
Early diagnosis, treatment needed for retinoblastoma patients
Early diagnosis and multifaceted treatment are important for the long-term survival rate of children with retinoblastoma, according to a study.
Malignant glaucoma responds well to treatment algorithm
A treatment algorithm of medication, laser hyaloidotomy, and vitrectomy or transscleral cyclophotocoagulation was successful in managing malignant glaucoma, according to a study.
Six factors may help predict advancement of iris nevus to melanoma
Iris nevus showed a low risk of advancing to melanoma, according to a study, and a mnemonic guide can be used to remember factors that may predict growth.